ISAF Hybrid 2023
BackOral Presentations
Friday 06 Oct, 09:00 AM -
10:30 AM Europe/Rome
Sala Germania
Oral Presentations
09:00
Real-world clusters of severe asthma from the Italian Registry on Severe Asthma (IRSA): a longitudinal Latent Class Analysis
09:11
Serum testosterone and obese asthma phenotypes: the story of men
09:22
Dupilumab Improves Lung Function and Reduces Exacerbation in Children (6 to 11 Years) With Moderate-to-Severe Asthma and High Blood Eosinophil Count at Baseline
09:33
Impact of Dupilumab Treatment on Clinical Remission in Patients with Uncontrolled, Moderate-to-Severe, Type 2 Asthma
09:44
Anaphylaxis due to anti-asthmatic biologics: analysis of VigiBase®, the WHO pharmacovigilance database
09:55
The protective effect of atopic diseases against pancreatic cancer are not associated with Th2-biomarkers
10:06
Withdrawal of inhaled corticosteroids in severe T2-low obesity-related asthma: results from an open-label randomized crossover trial
